Concord Drugs Limited (BOM:538965)

Concord Drugs Revenue

Concord Drugs had revenue of 102.76M INR in the quarter ending September 30, 2025, a decrease of -16.86%. This brings the company's revenue in the last twelve months to 450.74M, down -14.11% year-over-year. In the fiscal year ending March 31, 2025, Concord Drugs had annual revenue of 452.45M with 0.71% growth.

• Revenue (ttm): 450.74M
• Revenue Growth: -14.11%
• P/S Ratio: 2.49
• Revenue / Employee: 1.80M
• Employees: 250
• Market Cap: 1.12B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	452.45M	3.20M	0.71%
Mar 31, 2024	449.25M	-71.56M	-13.74%
Mar 31, 2023	520.81M	-69.62M	-11.79%
Mar 31, 2022	590.43M	75.99M	14.77%
Mar 31, 2021	514.44M	165.40K	0.03%